CSPC Pharmaceutical Group Limited. P/E Ratio

CSPC Pharmaceutical Group Limited. (CSPCY) currently reports a P/E ratio of 13.05. That is below the Healthcare sector average of 25.72. Use the charts on this page to explore CSPC Pharmaceutical Group Limited.'s P/E ratio history and peer comparisons.

CSPC Pharmaceutical Group Limited.'s P/E ratio of 13.05 is lower than the Healthcare sector average of 25.72. That is roughly 49.3% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

The P/E ratio is a valuation multiple that relates CSPC Pharmaceutical Group Limited.'s market price to a fundamental measure such as earnings, sales, or book value. At 13.05, CSPCY can look expensive or cheap only in context — versus its own history, growth rate, and Healthcare peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.

Start with the current P/E ratio of 13.05, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 25.72. From there, open related valuation or income-statement pages for CSPC Pharmaceutical Group Limited., and consider following CSPCY for alerts when major investors trade the stock.

CSPC Pharmaceutical Group Limited. is classified in the Healthcare sector. On P/E ratio, it currently shows 13.05 versus a sector average near 25.72. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CSPCY with unrelated industries.